Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
August-2018 Volume 40 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2018 Volume 40 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer

  • Authors:
    • Zhen Cui
    • Duojie Li
    • Jingjing Liu
    • Yajun Zhang
    • Hongbo Xu
    • Hongmei Yin
    • Hongwei Li
    • Gengming Wang
    • Hanfei Cai
    • Lei Zhang
    • Shimiao Duan
    • Hao Jiang
  • View Affiliations / Copyright

    Affiliations: Department of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China
  • Pages: 1147-1155
    |
    Published online on: May 31, 2018
       https://doi.org/10.3892/or.2018.6470
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate the role of G‑protein coupled receptor 120 (GPR120) in esophageal cancer and explore the related mechanisms. The expression of GPR120 in esophageal cancer tissues was examined by immunohistochemistry. Correlation analysis was performed to investigate the association between the level of GPR120 and clinical parameters. The expression of GPR120 was evaluated in esophageal cancer cell lines and the effects of GPR120 on cell proliferation, clone formation, migration and invasion were evaluated in an in vitro cell model and an in vivo ectopic tumor nude mice model. In addition, the effect of GPR120 on epithelial‑mesenchymal transition (EMT), PI3K and I‑κB pathway, as well as angiogenesis and inflammation‑related cytokines was explored in order to elucidate the underlying mechanisms. Significantly increased expression of GPR120 was observed in esophageal cancer tissues compared to normal tissues. The expression of GPR120 was significantly related with histological grade, TNM stage and lymph node metastasis. GPR120 knockdown significantly decreased cell proliferation, clone formation, migration and invasion in vitro and decreased tumor growth in vivo. Furthermore significantly increased levels of E‑cadherin and decreased levels of N‑cadherin and vimentin, decreased level of Akt phosphorylation and I‑κB phosphorylation, as well as decreased levels of vascular endothelial growth factor (VEGF), interleukin‑8 (IL‑8) and cyclooxygenase‑2 (Cox‑2) and its corresponding protein PGE2 were observed as the underlying mechanisms. In conclusion, we observed an increased level of GPR120 in esophageal cancer tissues, which served as a positive regulator of the development and progression of esophageal cancer. Multiple mechanisms including EMT, PI3K and I‑κB pathway, as well as angiogenesis and inflammation‑related cytokines were involved.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Napier KJ, Scheerer M and Misra S: Esophageal cancer: A review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Global Burden of Disease Cancer Collaboration; Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, et al: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 3:524–548. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Liang H, Fan JH and Qiao YL: Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 14:33–41. 2017. View Article : Google Scholar : PubMed/NCBI

5 

Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Pennathur A, Gibson MK, Jobe BA and Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Steury MD, McCabe LR and Parameswaran N: G protein-coupled receptor kinases in the inflammatory response and signaling. Adv Immunol. 136:227–277. 2017. View Article : Google Scholar : PubMed/NCBI

8 

Nohata N, Goto Y and Gutkind JS: Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer. J Hum Genet. 62:87–96. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Nogués L, Palacios-García J, Reglero C, Rivas V, Neves M, Ribas C, Penela P and Mayor F Jr: G protein-coupled receptor kinases (GRKs) in tumorigenesis and cancer progression: GPCR regulators and signaling hubs. Semin Cancer Biol. 78–90. 2018. View Article : Google Scholar : PubMed/NCBI

10 

Khalil BD, Hsueh C, Cao Y, Abi Saab WF, Wang Y, Condeelis JS, Bresnick AR and Backer JM: GPCR signaling mediates tumor metastasis via PI3Kβ. Cancer Res. 76:2944–2953. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Hara T, Kashihara D, Ichimura A, Kimura I, Tsujimoto G and Hirasawa A: Role of free fatty acid receptors in the regulation of energy metabolism. Biochim Biophys Acta. 1841:1292–1300. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM and Olefsky JM: GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 142:687–698. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Diakos CI, Charles KA, McMillan DC and Clarke SJ: Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 15:e493–e503. 2014. View Article : Google Scholar : PubMed/NCBI

14 

McCarty KS Jr, Miller LS, Cox EB, Konrath J and McCarty KS Sr: Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 109:716–721. 1985.

15 

Ji Y, Strawn TL, Grunz EA, Stevenson MJ, Lohman AW, Lawrence DA and Fay WP: Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts. Arterioscler Thromb Vasc Biol. 31:1781–1787. 2011. View Article : Google Scholar : PubMed/NCBI

16 

Golabek T, Bukowczan J, Chłosta P, Powroźnik J, Dobruch J and Borówka A: Obesity and prostate cancer incidence and mortality: A systematic review of prospective cohort studies. Urol Int. 92:7–14. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Kolodecik T, Shugrue C, Ashat M and Thrower EC: Risk factors for pancreatic cancer: Underlying mechanisms and potential targets. Front Physiol. 4:4152014. View Article : Google Scholar : PubMed/NCBI

18 

Ligibel JA and Strickler HD: Obesity and its impact on breast cancer: Tumor incidence, recurrence, survival, and possible interventions. Am Soc Clin Oncol Educ Book. 2013:52–59. 2013. View Article : Google Scholar

19 

Patterson RE, Rock CL, Kerr J, Natarajan L, Marshall SJ, Pakiz B and Cadmus-Bertram LA: Metabolism and breast cancer risk: Frontiers in research and practice. J Acad Nutr Diet. 113:288–296. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Van Kruijsdijk RC, van der Wall E and Visseren FL: Obesity and cancer: The role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev. 18:2569–2578. 2009. View Article : Google Scholar : PubMed/NCBI

21 

James FR, Wootton S, Jackson A, Wiseman M, Copson ER and Cutress RI: Obesity in breast cancer-what is the risk factor? Eur J Cancer. 51:705–720. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Fares H, Lavie CJ, DiNicolantonio JJ, O'Keefe JH and Milani RV: Omega-3 fatty acids: A growing ocean of choices. Curr Atheroscler Rep. 16:3892014. View Article : Google Scholar : PubMed/NCBI

23 

Simopoulos AP: An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 8:1282016. View Article : Google Scholar : PubMed/NCBI

24 

Farvid MS, Eliassen AH, Cho E, Liao X, Chen WY and Willett WC: Dietary fiber intake in young adults and breast cancer risk. Pediatrics. 137:e201512262016. View Article : Google Scholar : PubMed/NCBI

25 

Fabian CJ, Kimler BF and Hursting SD: Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Res. 17:622015. View Article : Google Scholar : PubMed/NCBI

26 

Zheng JS, Hu XJ, Zhao YM, Yang J and Li D: Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: Meta-analysis of data from 21 independent prospective cohort studies. BMJ. 346:f37062013. View Article : Google Scholar : PubMed/NCBI

27 

Nabavi SF, Bilotto S, Russo GL, Orhan IE, Habtemariam S, Daglia M, Devi KP, Loizzo MR, Tundis R and Nabavi SM: Omega-3 polyunsaturated fatty acids and cancer: Lessons learned from clinical trials. Cancer Metastasis Rev. 34:359–380. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Kraakman MJ, Murphy AJ, Jandeleit-Dahm K and Kammoun HL: Macrophage polarization in obesity and type 2 diabetes: Weighing down our understanding of macrophage function? Front Immunol. 5:4702014. View Article : Google Scholar : PubMed/NCBI

29 

Ballak DB, Van Diepen JA, Moschen AR, Jansen HJ, Hijmans A, Groenhof GJ, Leenders F, Bufler P, Boekschoten MV, Müller M, et al: IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun. 5:47112014. View Article : Google Scholar : PubMed/NCBI

30 

Katanov C, Lerrer S, Liubomirski Y, Leider-Trejo L, Meshel T, Bar J, Feniger-Barish R, Kamer I, Soria-Artzi G, Kahani H, et al: Regulation of the inflammatory profile of stromal cells in human breast cancer: Prominent roles for TNF-α and the NF-κB pathway. Stem Cell Res Ther. 6:872015. View Article : Google Scholar : PubMed/NCBI

31 

Zhu X, Du L, Feng J, Ling Y and Xu S: Clinicopathological and prognostic significance of serum cytokine levels in breast cancer. Clin Lab. 60:1145–1151. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Oh DY, Walenta E, Akiyama TE, Lagakos WS, Lackey D, Pessentheiner AR, Sasik R, Hah N, Chi TJ, Cox JM, et al: A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med. 20:942–947. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Wu Q, Wang H, Zhao X, Shi Y, Jin M, Wan B, Xu H, Cheng Y, Ge H and Zhang Y: Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma. Oncogene. 32:5541–5550. 2013. View Article : Google Scholar : PubMed/NCBI

34 

Chung H, Lee YS, Mayoral R, Oh DY, Siu JT, Webster NJ, Sears DD, Olefsky JM and Ellies LG: Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancer. Oncogene. 34:3504–3513. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cui Z, Li D, Liu J, Zhang Y, Xu H, Yin H, Li H, Wang G, Cai H, Zhang L, Zhang L, et al: G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer. Oncol Rep 40: 1147-1155, 2018.
APA
Cui, Z., Li, D., Liu, J., Zhang, Y., Xu, H., Yin, H. ... Jiang, H. (2018). G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer. Oncology Reports, 40, 1147-1155. https://doi.org/10.3892/or.2018.6470
MLA
Cui, Z., Li, D., Liu, J., Zhang, Y., Xu, H., Yin, H., Li, H., Wang, G., Cai, H., Zhang, L., Duan, S., Jiang, H."G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer". Oncology Reports 40.2 (2018): 1147-1155.
Chicago
Cui, Z., Li, D., Liu, J., Zhang, Y., Xu, H., Yin, H., Li, H., Wang, G., Cai, H., Zhang, L., Duan, S., Jiang, H."G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer". Oncology Reports 40, no. 2 (2018): 1147-1155. https://doi.org/10.3892/or.2018.6470
Copy and paste a formatted citation
x
Spandidos Publications style
Cui Z, Li D, Liu J, Zhang Y, Xu H, Yin H, Li H, Wang G, Cai H, Zhang L, Zhang L, et al: G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer. Oncol Rep 40: 1147-1155, 2018.
APA
Cui, Z., Li, D., Liu, J., Zhang, Y., Xu, H., Yin, H. ... Jiang, H. (2018). G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer. Oncology Reports, 40, 1147-1155. https://doi.org/10.3892/or.2018.6470
MLA
Cui, Z., Li, D., Liu, J., Zhang, Y., Xu, H., Yin, H., Li, H., Wang, G., Cai, H., Zhang, L., Duan, S., Jiang, H."G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer". Oncology Reports 40.2 (2018): 1147-1155.
Chicago
Cui, Z., Li, D., Liu, J., Zhang, Y., Xu, H., Yin, H., Li, H., Wang, G., Cai, H., Zhang, L., Duan, S., Jiang, H."G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer". Oncology Reports 40, no. 2 (2018): 1147-1155. https://doi.org/10.3892/or.2018.6470
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team